US Renal Care - Gallup
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Block, Geoffrey A
ROQ-IT, NCT05951192: A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

Completed
4
161
US
Daprodustat, JESDUVROQ
USRC Kidney Research, GlaxoSmithKline
Anemia, Renal Insufficiency, Chronic, Renal Anemia
02/24
02/24
FRONTIER, NCT05085275: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Completed
3
289
US
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Auryxia, Placebo
USRC Kidney Research, Akebia Therapeutics
Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron
01/24
01/24
VOICE, NCT06520826: Vafseo Outcomes In-Center Experience

Recruiting
3
2200
US
Vadadustat, Vafseo, Erythropoiesis Stimulating Agent, Epoetin alfa (EPOGEN), Methoxy polyethylene glycol-epoetin beta (Mircera), or Darbepoetin alfa (Aranesp)
USRC Kidney Research, Akebia Therapeutics
Anemia of Chronic Kidney Disease
06/26
06/26
NCT05677971: Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Recruiting
3
160
Europe, Canada, US, RoW
Fazirsiran Injection, TAK-999, ARO-AAT, ADS-001, Placebo, Sodium chloride
Takeda, Takeda Development Center Americas, Inc.
Alpha1-Antitrypsin Deficiency
03/27
03/29
DISC-0974-103, NCT05745883: Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants with CKD and Anemia

Recruiting
1
50
US
DISC-0974, Placebo
Disc Medicine, Inc
Chronic Kidney Diseases, Anemia of Chronic Kidney Disease
09/25
05/26

Download Options